As per Moneycontrol report, Manipal Health Enterprises Ltd has submitted draft papers to the Securities and Exchange Board of India (SEBI) for the initiation of an initial public offering (IPO), seeking to raise ₹8,000 crore.
This initiative encompasses both a fresh issue and an offer for sale by existing shareholders.
The IPO structure involves a fresh issue of ₹8,000 crore alongside an offer for sale (OFS) up to 43.23 million shares from promoters and existing shareholders.
Prominent investors such as Imperius Healthcare Investments, Manipal Education and Medical Group, TPG SG Magazine, and Seventy Second Investment have declared their intention to participate in the OFS.
The primary utilisation of the funds is directed towards the repayment of debts amounting to ₹5,378 crore and the acquisition of a minority stake worth ₹574 crore in Sahyadri Hospitals.
As of September 30, 2025, Manipal Health had a total of 10,761 licensed beds across 38 hospitals, operating in 14 states and union territories.
On a pro forma basis, the network extends to 48 hospitals with 12,367 licensed beds.
The hospital chain served 7.19 million patients in FY25, underscoring its extensive reach in India's healthcare sector.
For the fiscal year 2025, Manipal Health recorded a revenue from operations of ₹9,263.56 crore on a pro forma basis, marking substantial growth from ₹6,171.63 crore in the previous year.
The company's net profit was reported at ₹534.7 crore, slightly up from ₹533.2 crore.
In terms of geographical distribution, Karnataka hosts the majority of the company's beds, followed by Maharashtra, Goa, and eastern regions including West Bengal and Odisha.
Read More: IPO Alert: Trenzet Infra Files Draft Papers with SEBI to Raise Funds for Expansion!
By January 31, 2026, Manipal Health's consolidated borrowings stood at ₹10,612.79 crore. The funds obtained from the IPO are expected to significantly alleviate the company's financial obligations, enhancing its fiscal stability and supporting expansion activities.
Manipal Health Enterprises' ₹8,000 crore IPO is designed not only to manage existing debts but also to bolster the company's operational capabilities through strategic acquisitions. The move reflects a commitment to solidifying its position in the healthcare market.
Disclaimer: This blog has been written exclusively for educational purposes. The securities or companies mentioned are only examples and not recommendations. This does not constitute a personal recommendation or investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.
Investments in the securities market are subject to market risks, read all the related documents carefully before investing.
Published on: Mar 24, 2026, 1:30 PM IST
Team Angel One
We're Live on WhatsApp! Join our channel for market insights & updates
Get the link to download the App
